-
1
-
-
59849083500
-
Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote
-
Ali R, Jain GK, Iqbal Z, Talegaonkar S, Pandit P, Sule S, Malhotra G, Khar RK, Bhatnagar A, Ahmad FJ Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote. Nanomedicine: NMB, 2009;5:55-63
-
(2009)
Nanomedicine: NMB
, vol.5
, pp. 55-63
-
-
Ali, R.1
Jain, G.K.2
Iqbal, Z.3
Talegaonkar, S.4
Pandit, P.5
Sule, S.6
Malhotra, G.7
Khar, R.K.8
Bhatnagar, A.9
Ahmad, F.J.10
-
2
-
-
84856446250
-
Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study
-
Baraket M, Oliver BG, Burgess JK, Lim S, King GG, Black JL Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respir Res, 2012;13:1-11
-
(2012)
Respir Res
, vol.13
, pp. 1-11
-
-
Baraket, M.1
Oliver, B.G.2
Burgess, J.K.3
Lim, S.4
King, G.G.5
Black, J.L.6
-
3
-
-
80051671352
-
Chlorine truck attack consequences and mitigation
-
Barrett AM, Adams PJ Chlorine truck attack consequences and mitigation. Risk Anal, 2011;31:1243-59
-
(2011)
Risk Anal
, vol.31
, pp. 1243-1259
-
-
Barrett, A.M.1
Adams, P.J.2
-
4
-
-
70449522988
-
Youan BB Formulation of dacarbazine-loaded cubosomes- part I: Influence of formulation variables
-
Bei D, Marszalek J, Youan BB Formulation of dacarbazine-loaded cubosomes- part I: influence of formulation variables. AAPS PharmSciTech, 2009;10:1032-9
-
(2009)
AAPS PharmSciTech
, vol.10
, pp. 1032-1039
-
-
Bei, D.1
Marszalek, J.2
-
5
-
-
59649084577
-
Nano-salbutamol dry powder inhalation: A new approach for treating broncho-constrictive conditions
-
Bhavna Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, Bhatnagar A Nano-salbutamol dry powder inhalation: A new approach for treating broncho-constrictive conditions. Eur J Pharm Biopharm, 2009; 71:282-91
-
(2009)
Eur J Pharm Biopharm
, vol.71
, pp. 282-291
-
-
Bhavna Ahmad, F.J.1
Mittal, G.2
Jain, G.K.3
Malhotra, G.4
Khar, R.K.5
Bhatnagar, A.6
-
6
-
-
79958190856
-
Usmani OS Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition
-
Biddiscombe MF, Meah SN, Underwood SR, Usmani OS Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. J Aerosol Med Pulm Drug Deliv, 2011;24:165-73
-
(2011)
J Aerosol Med Pulm Drug Deliv
, vol.24
, pp. 165-173
-
-
Biddiscombe, M.F.1
Meah, S.N.2
Underwood, S.R.3
-
7
-
-
84855197304
-
The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS
-
Buscher BA, Jägfeldt H, Sandman H, Brust-van Schaik R, van Schaik F, Brüll LP The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS. J Chromatogr B: Analyt Technol Biomed Life Sci, 2012;880:6-11
-
(2012)
J Chromatogr B: Analyt Technol Biomed Life Sci
, vol.880
, pp. 6-11
-
-
Buscher, B.A.1
Jägfeldt, H.2
Sandman, H.3
Brust-Van Schaik, R.4
Van Schaik, F.5
Brüll, L.P.6
-
8
-
-
79953893441
-
Formulations for pulmonary administration of anticancer agents to treat lung malignancies
-
Carvalho TC, Carvalho SR, McConville JT. Formulations for pulmonary administration of anticancer agents to treat lung malignancies. J Aerosol Med Pulm Drug Deliv, 2011;24:61-80
-
(2011)
J Aerosol Med Pulm Drug Deliv
, vol.24
, pp. 61-80
-
-
Carvalho, T.C.1
Carvalho, S.R.2
McConville, J.T.3
-
9
-
-
0024865698
-
Aerodynamic properties of elongated particles of cromoglycic acid
-
Chan HK, Gonda I. Aerodynamic properties of elongated particles of cromoglycic acid. J Aerosol Sci, 1989;20:157-68
-
(1989)
J Aerosol Sci
, vol.20
, pp. 157-168
-
-
Chan, H.K.1
Gonda, I.2
-
10
-
-
68149179477
-
Mometasone furoate: An inhaled glucocorticoid for the management of asthma in adults and children
-
Cowie RL, Giembycz MA, Leigh R. Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children. Expert Opin Pharmacother, 2009;10:2009-14
-
(2009)
Expert Opin Pharmacother
, vol.10
, pp. 2009-2014
-
-
Cowie, R.L.1
Giembycz, M.A.2
Leigh, R.3
-
11
-
-
78650697312
-
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization
-
Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm, 2011;77:26-35
-
(2011)
Eur J Pharm Biopharm
, vol.77
, pp. 26-35
-
-
Cun, D.1
Jensen, D.K.2
Maltesen, M.J.3
Bunker, M.4
Whiteside, P.5
Scurr, D.6
Foged, C.7
Nielsen, H.M.8
-
12
-
-
0037436978
-
A novel method for assessing dissolution of aerosol inhaler products
-
Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm, 2003;255:175-87
-
(2003)
Int J Pharm
, vol.255
, pp. 175-187
-
-
Davies, N.M.1
Feddah, M.R.2
-
13
-
-
0343176392
-
Toxic gas inhalation
-
do Pico GA. Toxic gas inhalation. Curr Opin Pulm Med, 1995;1:102-8
-
(1995)
Curr Opin Pulm Med
, vol.1
, pp. 102-108
-
-
Do Pico, G.A.1
-
14
-
-
0029091338
-
Fluticasone propionate - An update on preclinical and clinical experience
-
Fuller R, Johnson M, Bye A. Fluticasone propionate - an update on preclinical and clinical experience Respir Med, 1995;89 (Suppl A):3-18
-
(1995)
Respir Med
, vol.89
, Issue.SUPPL. A
, pp. 3-18
-
-
Fuller, R.1
Johnson, M.2
Bye, A.3
-
15
-
-
42649106878
-
Nanoparticles: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery: A review
-
Gill S, Benberg R, Ku T, Azarmi S, Roa W, Prenner EJ. Nanoparticles: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery: A review. J Biomed Nanotech, 2007;3:107-19
-
(2007)
J Biomed Nanotech
, vol.3
, pp. 107-119
-
-
Gill, S.1
Benberg, R.2
Ku, T.3
Azarmi, S.4
Roa, W.5
Prenner, E.J.6
-
16
-
-
54549098156
-
Aerosol delivery devices in the treatment of asthma
-
Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care, 2008;53:699-723
-
(2008)
Respir Care
, vol.53
, pp. 699-723
-
-
Hess, D.R.1
-
17
-
-
84859735921
-
Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery - A review for multidisciplinary researchers
-
Islam N, Cleary MJ. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery - a review for multidisciplinary researchers Med Eng Phys, 2012;34:409-27
-
(2012)
Med Eng Phys
, vol.34
, pp. 409-427
-
-
Islam, N.1
Cleary, M.J.2
-
18
-
-
0032891996
-
Comparative efficacy and safety of inhaled corticosteroids in asthma
-
Jackson LD, Polygenis D, McIvor RA, Worthington I. Comparative efficacy and safety of inhaled corticosteroids in asthma. Can J Clin Pharmacol, 1999;6:26-37
-
(1999)
Can J Clin Pharmacol
, vol.6
, pp. 26-37
-
-
Jackson, L.D.1
Polygenis, D.2
McIvor, R.A.3
Worthington, I.4
-
19
-
-
80051784244
-
Edetate calcium disodium nanoparticle dry powder inhalation: A novel approach against heavy metal decorporation
-
Kumar N, Soni S, Jaimini A, Ahmad FJ, Bhatnagar A, Mittal G. Edetate calcium disodium nanoparticle dry powder inhalation: a novel approach against heavy metal decorporation. Int J Pharm, 2011;416:376-83
-
(2011)
Int J Pharm
, vol.416
, pp. 376-383
-
-
Kumar, N.1
Soni, S.2
Jaimini, A.3
Ahmad, F.J.4
Bhatnagar, A.5
Mittal, G.6
-
20
-
-
0043170800
-
Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers
-
Larhrib H, Martin GP, Prime D, Marriott C. Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers. Eur J Pharm Sci, 2003;19:211-21
-
(2003)
Eur J Pharm Sci
, vol.19
, pp. 211-221
-
-
Larhrib, H.1
Martin, G.P.2
Prime, D.3
Marriott, C.4
-
21
-
-
0031925636
-
Protein deposition from dry powder inhalers: Fine particle multiplets as performance modifiers
-
Lucas P, Anderson K, Staniforth JN. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm Res, 1998;15:562-9
-
(1998)
Pharm Res
, vol.15
, pp. 562-569
-
-
Lucas, P.1
Anderson, K.2
Staniforth, J.N.3
-
22
-
-
52049113741
-
Ammonia - When something smells wrong
-
Makarovsky I, Markel G, Dushnitsky T, Eisenkraft A. Ammonia - when something smells wrong Isr Med Assoc J, 2008;10:537-43
-
(2008)
Isr Med Assoc J
, vol.10
, pp. 537-543
-
-
Makarovsky, I.1
Markel, G.2
Dushnitsky, T.3
Eisenkraft, A.4
-
23
-
-
84862893358
-
Salmeterol and fluticasone in young children with multiple-trigger wheeze
-
Mäkelä MJ, Malmberg LP, Csonka P, Klemola T, Kajosaari M, Pelkonen AS. Salmeterol and fluticasone in young children with multiple-trigger wheeze. Ann Allergy Asthma Immunol, 2012;109:65-70
-
(2012)
Ann Allergy Asthma Immunol
, Issue.109
, pp. 65-70
-
-
Mäkelä, M.J.1
Malmberg, L.P.2
Csonka, P.3
Klemola, T.4
Kajosaari, M.5
Pelkonen, A.S.6
-
25
-
-
84863896162
-
Nebulized corticosteroids in asthma and COPD: An Italian appraisal
-
Melani AS. Nebulized corticosteroids in asthma and COPD: An Italian appraisal. Respir Care, 2012;57(7):1161-74
-
(2012)
Respir Care
, vol.57
, Issue.7
, pp. 1161-1174
-
-
Melani, A.S.1
-
26
-
-
80051791169
-
-
Patent No 1536/DEL/2008
-
Mittal G, Singh T, Goomer NC, Bhatnagar A, Lulla A, Malhotra G, Kashyap R, Tripathi RP. Formulations and methods thereof for making radiolabeled dry powder. 2008; Patent No. 1536/DEL/2008
-
(2008)
Formulations and methods thereof for making radiolabeled dry powder
-
-
Mittal, G.1
Singh, T.2
Goomer, N.C.3
Bhatnagar, A.4
Lulla, A.5
Malhotra, G.6
Kashyap, R.7
Tripathi, R.P.8
-
27
-
-
78049432930
-
Acute accidental exposure to chlorine gas: Clinical presentation, pulmonary functions and outcomes
-
Mohan A, Kumar SN, Rao MH, Bollineni S, Manohar IC. Acute accidental exposure to chlorine gas: Clinical presentation, pulmonary functions and outcomes. Indian J Chest Dis Allied Sci, 2010;52:149-52
-
(2010)
Indian J Chest Dis Allied Sci
, vol.52
, pp. 149-152
-
-
Mohan, A.1
Kumar, S.N.2
Rao, M.H.3
Bollineni, S.4
Manohar, I.C.5
-
28
-
-
59849093388
-
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals
-
Murnane D, Martin GP, Marriott C. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals. J Pharm Sci, 2009;98:503-15
-
(2009)
J Pharm Sci
, vol.98
, pp. 503-515
-
-
Murnane, D.1
Martin, G.P.2
Marriott, C.3
-
29
-
-
0033044660
-
Fluticasone propionate powder: Oral corticosteroidsparing effect and improved lung function and quality of life in patients with severe chronic asthma
-
Nelson HS, Busse WW, de Boisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, et al. Fluticasone propionate powder: Oral corticosteroidsparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol, 1999;103:267-75
-
(1999)
J Allergy Clin Immunol
, vol.103
, pp. 267-275
-
-
Nelson, H.S.1
Busse, W.W.2
De Boisblanc, B.P.3
Berger, W.E.4
Noonan, M.J.5
Webb, D.R.6
Wolford, J.P.7
Mahajan, P.S.8
Hamedani, A.G.9
Shah, T.10
-
30
-
-
0024433602
-
Pressurized aerosol deposition in the human lung with and without an ''open'' spacer device
-
Newman SP, Clark AR, Talaee N, Clarke SW. Pressurized aerosol deposition in the human lung with and without an ''open'' spacer device. Thorax, 1989;44:706-10
-
(1989)
Thorax
, vol.44
, pp. 706-710
-
-
Newman, S.P.1
Clark, A.R.2
Talaee, N.3
Clarke, S.W.4
-
31
-
-
0019377972
-
Deposition of pressurised aerosols in the human respiratory tract
-
Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax, 1981;36:52-5
-
(1981)
Thorax
, vol.36
, pp. 52-55
-
-
Newman, S.P.1
Pavia, D.2
Moren, F.3
Sheahan, N.F.4
Clarke, S.W.5
-
32
-
-
0032144040
-
Gamma scintigraphy: An in vivo technique for assessing the equivalence of inhaled products
-
Newman SP, Wilding IR. Gamma scintigraphy: an in vivo technique for assessing the equivalence of inhaled products. Int J Pharm, 1998;170:1-9
-
(1998)
Int J Pharm
, vol.170
, pp. 1-9
-
-
Newman, S.P.1
Wilding, I.R.2
-
33
-
-
33845906339
-
Inhaling medicines: Delivering drugs to the body through the lungs
-
Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov, 2007;6:67-74
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 67-74
-
-
Patton, J.S.1
Byron, P.R.2
-
34
-
-
49149092538
-
Upper and lower respiratory diseases after occupational and environmental disasters
-
Prezant DJ, Levin S, Kelly KJ, Aldrich TK. Upper and lower respiratory diseases after occupational and environmental disasters. Mt Sinai J Med, 2008;75:89-100
-
(2008)
Mt Sinai J Med
, vol.75
, pp. 89-100
-
-
Prezant, D.J.1
Levin, S.2
Kelly, K.J.3
Aldrich, T.K.4
-
35
-
-
84880914378
-
Q3C - Tables and list In: Guidance for industry
-
Accessed 12 October 2012
-
Q3C - Tables and List In: Guidance for Industry, ICH Guidelines for Impurities: Residual Solvents. 2012; pp. 5-8 Availableat: http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/default.htm. Accessed 12 October 2012
-
(2012)
ICH Guidelines for Impurities: Residual Solvents
, pp. 5-8
-
-
-
36
-
-
17844407027
-
Tc-99m isoniazid: a specific agent for diagnosis of tuberculosis
-
Singh AK, Verma J, Bhatnagar A, Sen S, Bose M. Tc-99m isoniazid: a specific agent for diagnosis of tuberculosis. World J Nucl Med, 2003;2:292-305
-
(2003)
World J Nucl Med
, vol.2
, pp. 292-305
-
-
Singh, A.K.1
Verma, J.2
Bhatnagar, A.3
Sen, S.4
Bose, M.5
-
37
-
-
79957519114
-
Formulation development and optimization of alpha ketoglutarate nanoparticles for cyanide poisoning
-
Sultana S, Talegaonkar S, Ali R, Mittal G, Bhatnagar A, Ahmad FJ. Formulation development and optimization of alpha ketoglutarate nanoparticles for cyanide poisoning. Powder Technol, 2011;211:1-9
-
(2011)
Powder Technol
, vol.211
, pp. 1-9
-
-
Sultana, S.1
Talegaonkar, S.2
Ali, R.3
Mittal, G.4
Bhatnagar, A.5
Ahmad, F.J.6
-
38
-
-
4444241635
-
Acute respiratory effects of exposure to ammonia on healthy persons
-
Sundblad BM, Larsson BM, Acevedo F, Ernstgard L, Johanson G, Larsson K, Palmberg L. Acute respiratory effects of exposure to ammonia on healthy persons. Scand J Work Environ Health, 2004;30:313-21
-
(2004)
Scand J Work Environ Health
, vol.30
, pp. 313-321
-
-
Sundblad, B.M.1
Larsson, B.M.2
Acevedo, F.3
Ernstgard, L.4
Johanson, G.5
Larsson, K.6
Palmberg, L.7
-
39
-
-
9644255612
-
Prediction of aerodynamic diameter of particles with rough surfaces
-
Tang P, Chan HK, Raper JA. Prediction of aerodynamic diameter of particles with rough surfaces. Powder Technol, 2004;147:64-78
-
(2004)
Powder Technol
, vol.147
, pp. 64-78
-
-
Tang, P.1
Chan, H.K.2
Raper, J.A.3
-
40
-
-
0032987469
-
Effect of inhaled corticosteroids on bronchial responsiveness in patients with ''corticosteroid naïve'' mild asthma: A meta-analysis
-
van Grunsven PM, van Schayck CP, Molema J, Akkermans RP, van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with ''corticosteroid naïve'' mild asthma: a meta-analysis. Thorax, 1999;54:316-22
-
(1999)
Thorax
, vol.54
, pp. 316-322
-
-
Van Grunsven, P.M.1
Van Schayck, C.P.2
Molema, J.3
Akkermans, R.P.4
Van Weel, C.5
-
41
-
-
77957891554
-
Chlorine gas inhalation: Human clinical evidence of toxicity and experience in animal models
-
White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc, 2010;7:257-63
-
(2010)
Proc Am Thorac Soc
, vol.7
, pp. 257-263
-
-
White, C.W.1
Martin, J.G.2
-
42
-
-
0035113080
-
The toxicology of chlorine
-
Winder C. The toxicology of chlorine. Environ Res, 2001;85:105-14.
-
(2001)
Environ Res
, vol.85
, pp. 105-114
-
-
Winder, C.1
|